June 26, 2020
Grifols discloses transfers of value made to European healthcare professionals and health-sector organizations in 2019
The company has released voluntary disclosures since 2015 in accordance with the EFPIA Disclosure code
- In line with its commitment to transparency, Grifols has disclosed for the fifth consecutive year all payments and other transfers of value related to medicines and medical technology made to healthcare professionals and health-sector organizations in the several European countries included within the EFPIA’s scope, including Spain.
- Total amount of Grifols’ transfers of value in Europe in 2019 was Euro 15.6 million. This is 27% higher than in 2018 due to the 28% increase in R&D-related transfers, which amounted to Euro 11.3 million in 2019 and represented 72% of total transfers in this period.
- In Spain, the evolution in 2019 was similar to that registered in Europe. Transfers of value grew by 24% to Euro 8.6 million due to the increase in those related to R&D, which was up by 23% to Euro 7.2 million.
- Spain generated 55% of the group’s total transfers in Europe in 2019 and 64% of those related to R&D.
- In 2019, Grifols made transfers of value to 297 healthcare professionals in Spain that amounted to Euro 383,014 (Euro 399,762 in 2018) and 79 health organizations, which totaled Euro 944,137 (Euro 625,805 in 2018).
- The EFPIA Code of Practice, which promotes transparency in industry interactions with healthcare professionals, healthcare organizations and patient organizations, applies specifically to medicines. Nonetheless Grifols expands its scope to include transfers unrelated to medications, as well as to the company’s three main divisions: Bioscience, Diagnostic and Hospital.
- In addition to Europe, Grifols applies this policy of transparency in the United States as required by the regulatory body (Centers for Medicare & Medicaid Services, CMS).
- All related information is public and available on the Grifols' corporate website: www.grifols.com
Information Published in Accordance with the EFPIA Code of Practice
Grifols has voluntarily committed to publishing, on its website and on any specific platform required by each country, information on transfers of value to health professionals and health sector organizations corresponding to each reporting period. The company will keep this information publicly available for three years and conserve it for six years.
Depending on the type of activity, the published information includes: donations and subsidies; corporate contributions for events, such as membership fees for healthcare professionals and sponsorship agreements with healthcare organizations, as well as payments to third parties designated to manage the event on their behalf; fees paid for consulting services and projects; travel and accommodation expenses incurred in relation to any of the aforementioned activities; and payments and other transfers of value related to R&D activities.
Specifically, the code of conduct is applied in the following European countries: Austria, Belgium, Bosnia & Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine and the United Kingdom.